Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

roche

Roche’s Tecentriq scores approvals in metastatic lung and bladder cancer

September 27, 2017
Research and Development, Sales and Marketing Cancer, EMA, EU, European Commission, Roche, bladder cancer, immunotherapy, lung cancer, pharma, tecentriq

It’s good news for Roche as the company’s immunotherapy drug Tecentriq secures approval from the European Commission to be used …

News
acute_leukemia-all

Roche and AbbVie’s leukaemia combo smashes Phase 3 endpoint

September 19, 2017
Manufacturing and Production, Research and Development AbbVie, Rituxan, Roche, Venclexta, Venclyxto, leukaemia, pharma, pharmaceutical

Venclexta/Venclyxto (venetoclax), Roche and AbbVie’s oral B-cell lymphoma-2 (BCL-2) inhibitor, successfully met its primary endpoint in Phase 3 trials, providing …

News
roche__tree

FDA locks down combo immunotherapy trials, Roche added to hold

September 19, 2017
Manufacturing and Production, Sales and Marketing Roche, biotech, drugs, immunotherapy, pharma, pharmaceutical, tecentriq

The FDA has moved to ensure that all immunotherapy trials studying PD-1/L1 agents, alongside immunomodulatory medicines in certain blood cancers …

News
novartis_window

Melanoma treatment: Novartis posts success, Roche stumbles

September 11, 2017
Research and Development, Sales and Marketing Novartis, Roche, biotech, drugs, melanoma, pharma, pharmaceutical

In a perfect example of the competitive nature of the pharmaceutical industry, just as one company posted success in one …

News
genentechlr

FDA approves treatment to counter CAR-T side-effects

August 31, 2017
Medical Communications, Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical

On the day that FDA announced the first CAR-T therapy would be given market authorisation, it also announced that a …

News

Roche receives FDA Priority Review for drug with potted history

August 24, 2017
Sales and Marketing Roche, biotech, drugs, emicizumab, pharma, pharmaceutical

Roche, alongside its subsidiary, Genentech, announced that it has received Priority Review for its haemophilia A drug, emicizumab, and that …

News
shire_image

Shire and Roche haemophilia spat spills into court

July 10, 2017
Sales and Marketing Roche, Shire, haemophilia

Roche released new scientific data at a conference in Berlin regarding its developmental drug in haemophilia, emicizumab, and Shire chose …

News
roche

Roche haemophilia therapy cuts bleed rate by 87%

June 26, 2017
Research and Development, Sales and Marketing Roche, haemophilia

Roche has revealed new data on its investigational haemophilia therapy ACE910 (emicizumab) which shows an 87% reduction in bleed rate …

News
novartis_window

Novartis receives European biosimilar approval for Roche blockbuster

June 19, 2017
Sales and Marketing Novartis, Rituxan, Rixathon, Roche

Sandoz, a division within Novartis, has received European Commission approval for its biosimilar version of Roche’s Rituxan (also known as …

News
roche__tree

From pipeline to patients: Navigating treatments through the UK system

June 15, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, pipeline

Pharmafocus spoke to Karen Lightning-Jones, Integrated Franchise Leader, Pipeline, to discuss the current UK climate for successfully developing drugs to …

Feature
hoffman

Silence Therapeutics instate new COO

June 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, Silence Therapeutics

Silence Therapeutics, a company focused on developing medicines through the body’s natural mechanism of RNA interference, has appointed a new …

Appointment
valium_10mg_roche

Evidence of tampering with Valium medication in Australia

May 31, 2017
Medical Communications, Research and Development Roche, valium

Roche, the supplier of Valium in Australia, had notified the Therapeutic Goods Administration (TGA) that it had discovered evidence of …

News
pharmafocus_june_2017_cover

The June 2017 issue of Pharmafocus is now live!

May 23, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pharmafocus, Roche, Takeda, UK, brexit, data management, market access, neurological disorders

The latest edition of Pharmafocus is available to read online now!

News
rocherooflr

Roche blockbuster immunotherapy Tecentriq outclassed by chemo in latest trial

May 10, 2017
Research and Development, Sales and Marketing Roche, tecentriq

It has been revealed that Roche’s immuno-oncology drug Tecentriq (atezolizumab) has failed to hit its primary endpoint in a follow-up …

News
world_health_organization_flag

WHO aims to increase uptake of biosimilars in poorer countries

May 4, 2017
Medical Communications, Research and Development Cancer, Roche, WHO, biosimilars

The WHO has announced that it will launch a project to prequalify biosimilar medicines for the treatment of certain cancers. …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025